Our Pipeline involve both topical and oral programs:
- The topical program is focused on the development of dermatology products for difficult to treat skin diseases.
- The oral program is focused on the treatment of autoimmune diseases and neuropathic pain.
| Administration | Indication | Preclinical | Phase-1(PoC) | Phase-2 & 3 |
|---|---|---|---|---|
| Topical | Atopic Dermatitis (Pruritus) | |||
| Acne Vulgaris | ||||
| Alopecia Areata | ||||
| Oral | Autoimmune Diseases | |||
| Neuropathic Pain |